These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38710499)

  • 1. Starting GLP-1 therapy may induce impulse control disorders.
    Playford RJ; Deahl M
    QJM; 2024 May; ():. PubMed ID: 38710499
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and treatment of impulse control disorders in patients with movement disorders.
    Mestre TA; Strafella AP; Thomsen T; Voon V; Miyasaki J
    Ther Adv Neurol Disord; 2013 May; 6(3):175-88. PubMed ID: 23634190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline.
    Li S; Vandvik PO; Lytvyn L; Guyatt GH; Palmer SC; Rodriguez-Gutierrez R; Foroutan F; Agoritsas T; Siemieniuk RAC; Walsh M; Frere L; Tunnicliffe DJ; Nagler EV; Manja V; Åsvold BO; Jha V; Vermandere M; Gariani K; Zhao Q; Ren Y; Cartwright EJ; Gee P; Wickes A; Ferns L; Wright R; Li L; Hao Q; Mustafa RA
    BMJ; 2021 May; 373():n1091. PubMed ID: 33975892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review.
    Broen M; Duits A; Visser-Vandewalle V; Temel Y; Winogrodzka A
    Parkinsonism Relat Disord; 2011 Jul; 17(6):413-7. PubMed ID: 21382739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
    Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
    Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Glycemic Control from GLP-1RA Therapy with and Without Concurrent Insulin in Patients with Type 2 Diabetes.
    Singhal M; Unni S; Schauerhamer M; Nguyen H; Hurd J; McAdam-Marx C
    J Manag Care Spec Pharm; 2017 Mar; 23(3):267-275. PubMed ID: 28230449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control symptoms in patients with Parkinson's disease: The influence of dopaminergic agonist.
    Vargas AP; Vaz LS; Reuter A; Couto CM; Costa Cardoso FE
    Parkinsonism Relat Disord; 2019 Nov; 68():17-21. PubMed ID: 31621612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.
    Cormier-Dequaire F; Bekadar S; Anheim M; Lebbah S; Pelissolo A; Krack P; Lacomblez L; Lhommée E; Castrioto A; Azulay JP; Defebvre L; Kreisler A; Durif F; Marques-Raquel A; Brefel-Courbon C; Grabli D; Roze E; Llorca PM; Ory-Magne F; Benatru I; Ansquer S; Maltête D; Tir M; Krystkowiak P; Tranchant C; Lagha-Boukbiza O; Lebrun-Vignes B; Mangone G; Vidailhet M; Charbonnier-Beaupel F; Rascol O; Lesage S; Brice A; Tezenas du Montcel S; Corvol JC;
    Mov Disord; 2018 Dec; 33(12):1878-1886. PubMed ID: 30444952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
    Biundo R; Weis L; Abbruzzese G; Calandra-Buonaura G; Cortelli P; Jori MC; Lopiano L; Marconi R; Matinella A; Morgante F; Nicoletti A; Tamburini T; Tinazzi M; Zappia M; Vorovenci RJ; Antonini A
    Mov Disord; 2017 Nov; 32(11):1557-1565. PubMed ID: 28960475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels.
    Voon V; Rizos A; Chakravartty R; Mulholland N; Robinson S; Howell NA; Harrison N; Vivian G; Ray Chaudhuri K
    J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):148-52. PubMed ID: 23899625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
    Auyeung M; Tsoi TH; Tang WK; Cheung CM; Lee CN; Li R; Yeung E
    Parkinsonism Relat Disord; 2011 Sep; 17(8):635-7. PubMed ID: 21705258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulse-control disorders in a college sample: results from the self-administered Minnesota Impulse Disorders Interview (MIDI).
    Odlaug BL; Grant JE
    Prim Care Companion J Clin Psychiatry; 2010; 12(2):. PubMed ID: 20694115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucine (and lysine) increased plasma levels of the satiety hormone cholecystokinin (CCK), and phenylalanine of the incretin glucagon-like peptide 1 (GLP-1) after oral gavages in pigs.
    Müller M; Xu C; Navarro M; Masiques NE; Tilbrook A; van Barneveld R; Roura E
    J Anim Sci; 2023 Jan; 101():. PubMed ID: 37233611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Outcomes After Initiating Triple Antidiabetic Therapy with a GLP-1 RA in an Integrated Health Care System.
    Lee SM; Aboubechara N; Niu F; Ledesma VM; Patel YA; Millares M; Hui RL
    J Manag Care Spec Pharm; 2019 Mar; 25(3):350-356. PubMed ID: 30816819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulse control disorders in adult psychiatric inpatients.
    Grant JE; Levine L; Kim D; Potenza MN
    Am J Psychiatry; 2005 Nov; 162(11):2184-8. PubMed ID: 16263865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Problematic Internet Use May Help Identify Impulse Control Disorders in Parkinson's Disease.
    Kovács M; Makkos A; Pintér D; Juhász A; Darnai G; Karádi K; Janszky J; Kovács N
    Behav Neurol; 2019; 2019():4925015. PubMed ID: 30863462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional inhibitory control dynamics in impulse control disorders in Parkinson's disease.
    Paz-Alonso PM; Navalpotro-Gomez I; Boddy P; Dacosta-Aguayo R; Delgado-Alvarado M; Quiroga-Varela A; Jimenez-Urbieta H; Carreiras M; Rodriguez-Oroz MC
    Mov Disord; 2020 Feb; 35(2):316-325. PubMed ID: 31710401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease.
    Tessitore A; De Micco R; Giordano A; di Nardo F; Caiazzo G; Siciliano M; De Stefano M; Russo A; Esposito F; Tedeschi G
    Mov Disord; 2017 Dec; 32(12):1710-1719. PubMed ID: 28949049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulse control disorders are associated with multiple psychiatric symptoms in Parkinson's disease.
    Jaakkola E; Kaasinen V; Siri C; Martikainen K; Cilia R; Niemelä S; Joutsa J
    J Parkinsons Dis; 2014; 4(3):507-15. PubMed ID: 25112222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.